Pharmaids Pharmaceuticals share news and announcements

BSE: 524572Pharmaceuticals & BiotechnologySmall Cap

₹28.92₹0.63 (2.23%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹28.29.

52-week range of traded prices to 23 Oct 2026

₹25.60Low, 1 Jun 2026₹53.90High, 9 Dec 2025

Market cap: ₹102 Cr2,774th largest listed
P/E: Lossover the last 12 months
P/B: 2.1
Dividend yield: Nonein the last 12 months
ROE: −8.5%
ROE without one-offs: −21.1%
ROCE: −15.8%
Debt to equity: 0.44
Volume, BSE: 1,482

Pharmaids Pharmaceuticals share news and announcements

617 announcements, routine notices left out, newest first. Page 5 of 13.

Nov 2023
- 11 Nov · Results
  Financial Results for the for the quarter and half year ended on 30th September 2023 (opens in a new tab)
- 11 Nov · Board meeting
  Outcome of the Board Meeting held on 11th September , 2023 for approval of unaudited Standalone and Consolidated financial results for the quarter and half year ended 30th September 2023. (opens in a new tab)
- 6 Nov · Board meeting
  Meeting on 11 Nov 2023: quarterly results
- 4 Nov · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 ,inter alia, to consider and approve Unaudited Financial .... (opens in a new tab)
Oct 2023
Sep 2023
- 26 Sep · Business
  Intimation regarding the acquisition of two land parcels by the company on Monday, 25 September 2023. (opens in a new tab)
- 25 Sep · Meeting
  Voting results along with scrutinizer report of the 34th Annual General Meeting held on Friday, 22 September 2023. (opens in a new tab)
- 22 Sep · Meeting
  Outcome of the 34th Annual general meeting of the Company held on 22nd September, 2023 at 12:30 p.m. through VC/OAVM. (opens in a new tab)
- 1 Sep · Intimation Of Submission Of Application To BSE Limited For Reclassification Of Promoters Of Pharmaids Pharmaceuticals Limited ('Company')
  Intimation of submission of application to BSE Limited for Reclassification of promoters of Pharmaids Pharmaceuticals Limited ("Company") from the "Promoter and Promoter Group" Category .... (opens in a new tab)
Aug 2023
- 31 Aug · Meeting
  The 34th Annual General Meeting is scheduled to be held on Friday, 22nd September, 2023 at 12:30 P.M. through VC/OAVM. Please find the Annual Report containing Notice of the AGM for your .... (opens in a new tab)
- 30 Aug · Business
  Our previous discloure, dated August 4, 2023, inadvertently contained incorrect figure in the funds utilized for the quater ended 30 june, 2023 and wish to rectify it promptly to ensure .... (opens in a new tab)
- 29 Aug · Management
  Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, the board of directors of the company in their meeting held on 29th August 2023, Considered the Resignation of Mr. Venkata .... (opens in a new tab)
- 29 Aug · Management
  Disclosure under Regulation 30 of SEBI Listing Regulations, 2015. the Baord in its meeting held on 29th Aug 2023, approved the appointment of Mr. Shreedhara Shetty, as Additonal Director .... (opens in a new tab)
- 29 Aug · Board meeting
  Outcome of the Board Meeting held on 29th August , 2023 for approval of Annual Financial Statements for the financial year 2022-23 and AGM related matters. (opens in a new tab)
- 23 Aug · Board meeting
  Meeting on 29 Aug 2023
- 22 Aug · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
- 18 Aug · Business
  Revised Disclosure on Acquisition of stake in the Anugraha Chemicals "The firm"under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 10 Aug · Business
  This is furtherance to our intimation dated 17th January, 2023, regarding investment in Anugraha Chemicals ("the Firm"), a partnership firm registered under the Karnataka Partnership (Registration .... (opens in a new tab)
- 4 Aug · Business
  And SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there is no deviation(s) or varitaions(s) in .... (opens in a new tab)
- 4 Aug · Submission Of Minutes Of The BOD Meeting Under Regulation 31A(8) Wherein The Proposal Of The Promoter Seeking Reclassification Has Been Considered.
  Pursuant to the provisions of regulation 30 and 31A(8) of the Listing Regulations, we wish to inform you that the board at its meeting held today, i.e., 04th August 2023, has inter alia .... (opens in a new tab)
- 4 Aug · Management
  M/s Kashinath Sahu & Co., Practicing Company Secretaries has been re-appointed as a secretarial auditor of the company for the financial year 2023-2024. (opens in a new tab)
- 4 Aug · Results
  Unaudited Standalone and Consolidated financial results along with Limited Review Report for the quarter and three months ended 30th June, 2023. (opens in a new tab)
- 4 Aug · Results
  Outcome of the Board Meeting held on 04th August , 2023 for approval of unudited Standalone and Consolidated financial results for the quarter ended 30th June 2023. (opens in a new tab)
Jul 2023
- 28 Jul · Board meeting
  Meeting on 4 Aug 2023: quarterly results
- 28 Jul · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Unaudited Financial .... (opens in a new tab)
- 21 Jul · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category.
  This is to inform you that the company has received request letter from Ms. Abhilekha Jain, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter and .... (opens in a new tab)
- 14 Jul · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category
  This is t inform you that the Company has received request letter from Mr. Subhash Lalwani, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter and .... (opens in a new tab)
- 14 Jul · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category
  This is to inform you that the company has received request letters from Mr. Subhash B Lalwani, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter .... (opens in a new tab)
- 11 Jul · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category
  This is to inform you that the Company has received request letters from Veena Lalwani, Abhishek Jain and Ghisulal Jain, members belonging to "Promoter and promoter group" seeking reclassification .... (opens in a new tab)
Jun 2023
- 27 Jun · Intimation Of Submission Of Application To BSE Limited For Reclassification Of Promoters Of Pharmaids Pharmaceuticals Limited ('Company')
  Intimation of submission of application to BSE Limited for reclassification of promoters of Pharmaids Pharmaceuticals Limited ('Company') from the 'Promoter and Promoter Group' category .... (opens in a new tab)
- 15 Jun · Announcement Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Address Of Registrar And Transfer Agent.
  This is to inform you about the change of office premises of Venture Capital & Corporate Investments Private Limited, the Registrar and Transfer Agent of the Company. (opens in a new tab)
- 13 Jun · Submission Of Minutes Of The BOD Meeting Under Regulation 31A(8) Wherein The Proposal Of The Promoter Seeking Reclassification Has Been Considered.
  Pursuant to the provisions of Regulations 30 and 31A(8) of the Listing Regulations and our board meeting outcome dated 29th May 2023, we wish to inform you that the Board, at its meeting .... (opens in a new tab)
May 2023
- 29 May · Business
  And SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there are no deviation(s) or variation(s) .... (opens in a new tab)
- 29 May · Submission Of Details Of Related Party Transaction For Half Year Ended 31.03.2023
  Submission of Related Party Transaction Report under regulation 23 of SEBI (LODR) Regulations, 2015, for the 2nd half year ended 31.03.2023. (opens in a new tab)
- 29 May · Results
  Submission of Audited Financial Results alonq with Auditors' Report for the quarter and Year Ended March 31, 2023 (opens in a new tab)
- 29 May · Results
  Outcome of the Board Meeting held on 29th May, 2023 for approval of Audited Standalone and Consolidated financial results (opens in a new tab)
- 23 May · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  Pursuant to approval of Registrar of Companies, Bangalore, the Registered Office of the Company now is Unit 201, 2nd Floor, Brigade Rubix, 20/14, HMT Factory Main Road, Peenya Plantation, .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 29 May 2023: audited results
- 23 May · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Audited Financial .... (opens in a new tab)
- 22 May · Outcome Of Circular Resolution Passed By Board Of Directors Of The Company On 22Nd May, 2023
  With reference to the above, we would like to inform you that Board of Directors of the Company has approved and passed resolutions by circulation on dated 22nd May, 2023 for acquisition .... (opens in a new tab)
Apr 2023
- 27 Apr · Business
  And SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there are no deviation(s) or variation(s) .... (opens in a new tab)
- 11 Apr · Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31.03.2023
  We enclose herewith copy of Certificate for the year ended 31.03.2023. Please .... (opens in a new tab)
- 5 Apr · Compliance Certificate By Compliance Officer & RTA For The Year Ended 31St March 2023
  Please find enclosed Compliance Certificate duly signed by RTA M/s Venture Capital & Corporate Investments Private Limited and Compliance Officer of the Company, pursuant to regulation .... (opens in a new tab)
- 3 Apr · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category
  This is to inform that Company has received request letter on 03rd April, 2023 from Mr. Babulal Jain, member belonging to the "Promoter and Promoter Group" of the Company for his reclassification .... (opens in a new tab)
Mar 2023
- 21 Mar · Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reclassification Of "Promoter And Promoter Group" Category To "Public" Category
  This is to inform that Company has received request letter dated 21st March, 2023 from Mrs. Umadevi Babulal Jain, member belonging to the "Promoter and Promoter Group" of the Company for .... (opens in a new tab)
Feb 2023
- 13 Feb · Board meeting
  Board of Directors of the Company have approved Unaudited Financial results for the quarter and nine months ended 31st December 2022 and taking land on sub-lease in its meeting held .... (opens in a new tab)
- 3 Feb · Board meeting
  Meeting on 13 Feb 2023: quarterly results

Pharmaids Pharmaceuticals share news and announcements

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Jul 2023

Jun 2023

May 2023

Apr 2023

Mar 2023

Feb 2023